CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 40 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $390,000 | +0.3% | 21,197 | 0.0% | 0.00% | – |
| Q3 2020 | $389,000 | +22.7% | 21,197 | 0.0% | 0.00% | – |
| Q2 2020 | $317,000 | -5.4% | 21,197 | 0.0% | 0.00% | – |
| Q1 2020 | $335,000 | -2.6% | 21,197 | 0.0% | 0.00% | – |
| Q4 2019 | $344,000 | +9.2% | 21,197 | 0.0% | 0.00% | – |
| Q3 2019 | $315,000 | -10.0% | 21,197 | 0.0% | 0.00% | – |
| Q2 2019 | $350,000 | -4.6% | 21,197 | 0.0% | 0.00% | – |
| Q1 2019 | $367,000 | -1.9% | 21,197 | 0.0% | 0.00% | – |
| Q4 2018 | $374,000 | -2.9% | 21,197 | 0.0% | 0.00% | – |
| Q3 2018 | $385,000 | -7.0% | 21,197 | 0.0% | 0.00% | – |
| Q2 2018 | $414,000 | +10250.0% | 21,197 | 0.0% | 0.00% | – |
| Q1 2018 | $4,000 | +100.0% | 21,197 | 0.0% | 0.00% | – |
| Q4 2017 | $2,000 | 0.0% | 21,197 | +30.2% | 0.00% | – |
| Q3 2017 | $2,000 | – | 16,285 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| S. MUOIO & CO. LLC | 52,468 | $964,000 | 1.05% |
| Olympiad Research LP | 54,795 | $1,007,000 | 0.58% |
| Alpine Global Management, LLC | 119,902 | $2,204,000 | 0.45% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 65,922 | $1,212,000 | 0.19% |
| First Trust Capital Management L.P. | 32,688 | $601,000 | 0.17% |
| GLAZER CAPITAL, LLC | 232,103 | $4,266,000 | 0.15% |
| Walleye Capital LLC | 105,000 | $1,930,000 | 0.13% |
| Yakira Capital Management, Inc. | 17,588 | $323,000 | 0.08% |
| Dynamic Technology Lab Private Ltd | 17,929 | $330,000 | 0.05% |
| EQUITEC PROPRIETARY MARKETS, LLC | 10,600 | $195,000 | 0.05% |